Prachi Umbarkar - Search Results

Year	Number of Results
2015	1
2016	1
2017	2
2018	1
2019	3
2020	4
2021	3
2022	2
2023	1

1

Fibroblast GSK-3α Promotes Fibrosis via RAF-MEK-ERK Pathway in the Injured Heart.

Umbarkar P, Tousif S, Singh AP, Anderson JC, Zhang Q, Tallquist MD, Woodgett J, Lal H. Umbarkar P, et al. Circ Res. 2022 Sep 16;131(7):620-636. doi: 10.1161/CIRCRESAHA.122.321431. Epub 2022 Sep 2. Circ Res. 2022. PMID: 36052698

2

Targeting 5-HT_2B Receptor Signaling Prevents Border Zone Expansion and Improves Microstructural Remodeling After Myocardial Infarction.

Snider JC, Riley LA, Mallory NT, Bersi MR, Umbarkar P, Gautam R, Zhang Q, Mahadevan-Jansen A, Hatzopoulos AK, Maroteaux L, Lal H, Merryman WD. Snider JC, et al. Among authors: umbarkar p. Circulation. 2021 Mar 30;143(13):1317-1330. doi: 10.1161/CIRCULATIONAHA.120.051517. Epub 2021 Jan 21. Circulation. 2021. PMID: 33474971 Free PMC article.

3

Entanglement of GSK-3β, β-catenin and TGF-β1 signaling network to regulate myocardial fibrosis.

Guo Y, Gupte M, Umbarkar P, Singh AP, Sui JY, Force T, Lal H. Guo Y, et al. Among authors: umbarkar p. J Mol Cell Cardiol. 2017 Sep;110:109-120. doi: 10.1016/j.yjmcc.2017.07.011. Epub 2017 Jul 27. J Mol Cell Cardiol. 2017. PMID: 28756206 Free PMC article. Review.

4

Repurposing Nintedanib for pathological cardiac remodeling and dysfunction.

Umbarkar P, Singh AP, Tousif S, Zhang Q, Sethu P, Lal H. Umbarkar P, et al. Pharmacol Res. 2021 Jul;169:105605. doi: 10.1016/j.phrs.2021.105605. Epub 2021 May 13. Pharmacol Res. 2021. PMID: 33965510 Free PMC article.

5

Cardiotoxicity of the BCR-ABL1 tyrosine kinase inhibitors: Emphasis on ponatinib.

Singh AP, Umbarkar P, Tousif S, Lal H. Singh AP, et al. Among authors: umbarkar p. Int J Cardiol. 2020 Oct 1;316:214-221. doi: 10.1016/j.ijcard.2020.05.077. Epub 2020 May 27. Int J Cardiol. 2020. PMID: 32470534 Free PMC article. Review.

6

Mechanisms of Fibroblast Activation and Myocardial Fibrosis: Lessons Learned from FB-Specific Conditional Mouse Models.

Umbarkar P, Ejantkar S, Tousif S, Lal H. Umbarkar P, et al. Cells. 2021 Sep 14;10(9):2412. doi: 10.3390/cells10092412. Cells. 2021. PMID: 34572061 Free PMC article. Review.

7

Inhibition of GSK-3 to induce cardiomyocyte proliferation: a recipe for in situ cardiac regeneration.

Singh AP, Umbarkar P, Guo Y, Force T, Gupte M, Lal H. Singh AP, et al. Among authors: umbarkar p. Cardiovasc Res. 2019 Jan 1;115(1):20-30. doi: 10.1093/cvr/cvy255. Cardiovasc Res. 2019. PMID: 30321309 Free PMC article. Review.

8

Ponatinib Drives Cardiotoxicity by S100A8/A9-NLRP3-IL-1β Mediated Inflammation.

Tousif S, Singh AP, Umbarkar P, Galindo C, Wheeler N, Toro Cora A, Zhang Q, Prabhu SD, Lal H. Tousif S, et al. Among authors: umbarkar p. Circ Res. 2023 Feb 3;132(3):267-289. doi: 10.1161/CIRCRESAHA.122.321504. Epub 2023 Jan 10. Circ Res. 2023. PMID: 36625265 Free article.

9

Isoform-Specific Role of GSK-3 in High Fat Diet Induced Obesity and Glucose Intolerance.

Gupte M, Tousif S, Lemon JJ, Toro Cora A, Umbarkar P, Lal H. Gupte M, et al. Among authors: umbarkar p. Cells. 2022 Feb 5;11(3):559. doi: 10.3390/cells11030559. Cells. 2022. PMID: 35159367 Free PMC article.

10

Mechanistic Insights of Empagliflozin-Mediated Cardiac Benefits: Nearing the Starting Line : Editorial to: "Empagliflozin Improves Left Ventricular Diastolic Dysfunction in a Genetic Model of Type 2 Diabetes" by N. Hammoudi et al.

Gupte M, Umbarkar P, Lal H. Gupte M, et al. Among authors: umbarkar p. Cardiovasc Drugs Ther. 2017 Jun;31(3):229-232. doi: 10.1007/s10557-017-6741-2. Cardiovasc Drugs Ther. 2017. PMID: 28733758 Free PMC article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results